Cowen And Company, LLC Dbv Technologies S.A. Transaction History
Cowen And Company, LLC
- $2.98 Billion
- Q1 2024
A detailed history of Cowen And Company, LLC transactions in Dbv Technologies S.A. stock. As of the latest transaction made, Cowen And Company, LLC holds 39,536 shares of DBVT stock, worth $33,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,536
Previous 50,986
22.46%
Holding current value
$33,210
Previous $48,000
39.58%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DBVT
# of Institutions
35Shares Held
37.7MCall Options Held
0Put Options Held
0-
Baker Bros. Advisors LP New York, NY14.6MShares$12.3 Million0.14% of portfolio
-
Braidwell LP Stamford, CT7.84MShares$6.59 Million0.19% of portfolio
-
Yiheng Capital Management, L.P. San Francisco, CA5.57MShares$4.68 Million0.23% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.11MShares$2.61 Million0.01% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.71MShares$2.28 Million0.27% of portfolio
About DBV Technologies S.A.
- Ticker DBVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,776,992
- Market Cap $158M
- Description
- DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...